Eli Lilly offers new weight loss drug to some patients before FDA approval

Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval. 

Moderna’s mRNA flu vaccine gets FDA approval: Here's what's different

The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.

Texas investigates American Academy of Pediatrics over childhood vaccine recommendations

The Texas Attorney General’s Office said Wednesday it has opened an investigation into the American Academy of Pediatrics (AAP) over the group’s promotion of childhood vaccines.

VA launches trial of GLP-1 drugs to treat alcohol use disorder in veterans

The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans.

Here's how much retiring in 2026 could cost you in health care expenses

A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads

Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy. 

Arizona toddler found alive in hospital morgue after being declared dead

An 18-month-old Gilbert boy was found breathing in a hospital morgue nearly five hours after being declared dead following a pool incident.

Obamacare premiums going up next year - Here's why

Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.

Medicare rolls out $50 GLP-1 drug program: What to know

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 program.  

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.

Vanessa Trump reveals breast cancer diagnosis

Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer and has started a treatment plan.

Texas Children's Hospital must build 'detransition clinic' after $10M settlement

Texas Children's Hospital is required to construct a "detransition clinic" as part of a $10 million settlement with the state and the Department of Justice.

California’s $1.3B Medicaid funding put on hold amid fraud suspicions

The Trump administration is widening its initiative to eliminate fraud in the federal health program, which includes a $1.3 billion deferral of Medicaid funding to California.